ICU Medical Management
Management Kriterienprüfungen 3/4
ICU Medical CEO ist Vivek Jain , ernannt in Feb 2014, hat eine Amtszeit von 10.75 Jahren. Die jährliche Gesamtvergütung beträgt $6.81M , bestehend aus 11.4% Gehalt und 88.6% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.79% der Aktien des Unternehmens, im Wert von $32.39M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 6.8 Jahre bzw. 6.8 Jahre.
Wichtige Informationen
Vivek Jain
Geschäftsführender
US$6.8m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 11.4% |
| Amtszeit als Geschäftsführer | 10.8yrs |
| Eigentum des Geschäftsführers | 0.8% |
| Durchschnittliche Amtszeit des Managements | 6.8yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 6.8yrs |
Jüngste Management Updates
Recent updates
ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets
Nov 15
A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Oct 01ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry
Aug 18ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly
Aug 07ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult
Jun 27ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price
Jun 23Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package
May 09Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S
Apr 26ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Mar 31Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?
Jan 31ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business
Jan 04These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively
Oct 28Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?
Oct 07ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Jul 19Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Jun 22Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt
Apr 03Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Feb 27ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Dec 07ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Sep 07ICU Medical Hit Hard As Smiths Medical Needs Significant TLC
Aug 20ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M
Aug 08FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious
Jul 20ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Jun 08ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value
Mar 25Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$111m |
| Jun 30 2024 | n/a | n/a | -US$71m |
| Mar 31 2024 | n/a | n/a | -US$59m |
| Dec 31 2023 | US$7m | US$775k | -US$30m |
| Sep 30 2023 | n/a | n/a | -US$28m |
| Jun 30 2023 | n/a | n/a | -US$48m |
| Mar 31 2023 | n/a | n/a | -US$46m |
| Dec 31 2022 | US$6m | US$756k | -US$74m |
| Sep 30 2022 | n/a | n/a | -US$39m |
| Jun 30 2022 | n/a | n/a | US$5m |
| Mar 31 2022 | n/a | n/a | US$41m |
| Dec 31 2021 | US$5m | US$650k | US$103m |
| Sep 30 2021 | n/a | n/a | US$109m |
| Jun 30 2021 | n/a | n/a | US$103m |
| Mar 31 2021 | n/a | n/a | US$94m |
| Dec 31 2020 | US$3m | US$650k | US$87m |
| Sep 30 2020 | n/a | n/a | US$81m |
| Jun 30 2020 | n/a | n/a | US$83m |
| Mar 31 2020 | n/a | n/a | US$87m |
| Dec 31 2019 | US$3m | US$650k | US$101m |
| Sep 30 2019 | n/a | n/a | US$73m |
| Jun 30 2019 | n/a | n/a | US$47m |
| Mar 31 2019 | n/a | n/a | US$55m |
| Dec 31 2018 | US$6m | US$650k | US$29m |
| Sep 30 2018 | n/a | n/a | US$86m |
| Jun 30 2018 | n/a | n/a | US$86m |
| Mar 31 2018 | n/a | n/a | US$18m |
| Dec 31 2017 | US$4m | US$650k | US$69m |
Vergütung im Vergleich zum Markt: VivekDie Gesamtvergütung ($USD6.81M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD6.57M).
Entschädigung vs. Einkommen: VivekDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.
Geschäftsführer
Vivek Jain (52 yo)
10.8yrs
Amtszeit
US$6,810,975
Vergütung
Mr. Vivek Jain has been an Independent Director of Envista Holdings Corporation since April 07, 2020. Mr. Jain has been Chairman and Chief Executive Officer of ICU Medical, Inc. since February 13, 2014. Mr...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Chairman of the Board | 10.8yrs | US$6.81m | 0.79% $ 32.4m | |
| President | less than a year | US$2.21m | 0.054% $ 2.2m | |
| CFO & Treasurer | 4.7yrs | US$4.39m | 0.10% $ 4.2m | |
| Chief Operating Officer | 6.8yrs | US$4.40m | keine Daten | |
| Corporate VP | 6.8yrs | US$2.47m | 0.018% $ 751.3k |
6.8yrs
Durchschnittliche Betriebszugehörigkeit
50yo
Durchschnittliches Alter
Erfahrenes Management: ICUIDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (6.8 ).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Chairman of the Board | 10.8yrs | US$6.81m | 0.79% $ 32.4m | |
| Independent Director | 8.8yrs | US$265.14k | 0.0087% $ 357.0k | |
| Independent Director | 2.9yrs | US$255.14k | 0.0064% $ 261.8k | |
| Independent Director | 6.8yrs | US$282.14k | 0.012% $ 507.2k | |
| Independent Director | 3.3yrs | US$255.14k | 0.0077% $ 316.0k | |
| Lead Independent Director | 9.3yrs | US$296.14k | 0.023% $ 927.8k | |
| Independent Director | 6.8yrs | US$255.14k | 0.012% $ 507.2k |
6.8yrs
Durchschnittliche Betriebszugehörigkeit
63yo
Durchschnittliches Alter
Erfahrener Vorstand: ICUIDie Vorstandsmitglieder gelten als erfahren (6.8 Jahre durchschnittliche Amtszeit).